Background
The treatment of aesthetically displeasing scars of the head and neck is challenging at times, although not without options. While removing one scar without leaving another is not possible, replacing an unfavorable scar with a more camouflaged one, or rendering an existing scar less noticeable, is possible.
By the time scar revision patients present to a physician, they have exhausted every means at their disposal to disguise the scar. These attempts at concealing the scar typically involve the use of cosmetics, clothing, and hairstyle modifications. While various treatments exist, none is perfect, and the cornerstone of any scar revision is a thorough understanding of the patients' dissatisfaction with their appearance and their expectations following treatment. Patients must understand that the best result may require multiple treatments and that initially, little improvement may be noticeable relative to the preexisting deformity.
Other considerations of paramount importance when considering scar revision include (1) whether the scar is in a position that compromises function and (2) if any revision might result in decreased function. As with any skin defect, the quality and availability of surrounding tissue must be assessed.[1, 2]
The Medscape Dermatology Surgery Resource Center and Aesthetic Medicine Resource Center may be helpful.
History of the Procedure
According to ancient Egyptian writing, scarification for aesthetic reasons dates back to 1700 BCE. Throughout history, different cultures have used scarring as a depiction of one's affiliation with a particular group, its exploits, or stature. In most cultures now however, scars on the head and neck are perceived as undesirable, and patients often present to their physician requesting revision to render their scars less noticeable.
Problem
In general, scar revision techniques are either operative or nonoperative in nature. More aesthetically pleasing scars are those that are less noticeable. Intuitively, this includes matching the surrounding skin in color, texture, distensibility, and elevation. The characteristics of scars are important relative to their surroundings. For example, scars often have fewer dermal appendages or lack them altogether. In areas of hair-bearing skin, a scar's lack of hair follicles is particularly noticeable. In other areas with sparse hair follicles, this is a desirable attribute of scars.
Patient characteristics also play a large factor in scarring, as does the quality of closure and the cleanliness of the wound. Patients at the extremes of age often scar to a greater degree. Young patients are more prone to excessive scar formation, while elderly persons are more prone to poor healing, owing to diminished fibroblast activity. Individuals with connective-tissue disease, diabetes mellitus, or vitamin deficiencies or those who return to activity too early may experience healing complications that result in greater scarring upon final closure.
Wounds that are poorly closed, undergo dehiscence, have necrosis of the skin edges, or have edges that are poorly approximated are more likely to heal with unsightly scarring. Likewise, wounds that become infected or undergo foreign body reactions to sutures more frequently yield poor cosmetic results. Proper screening of patients prior to surgery, proper nutrition, good technique, and conscientious wound care dramatically favor faster wound healing and more aesthetic results.
Etiology
Before considering scar revision, the treating physician must have an understanding of wound healing and how scar tissue forms. Wound healing progresses in 3 phases: an inflammatory phase, a granulation phase, and the final, remodeling phase.
Inflammation is an immediate physiologic response to any injury to the body. In the skin, it serves the additional role of helping to contain and repel any organisms or foreign materials introduced into the tissues by a variety of traumas, including surgical incisions. The various mediators of inflammation are the first materials released in the wound, including activated complement, transforming growth factor-beta, circulating monocytes, tissue macrophages, neutrophils, platelets, clotting factors, and serum proteins, among others. Damaged collagen fibers promote platelet aggregation in the wound. Later, collagen provides the scaffold for wound healing as the major constituent of the extracellular matrix. This primary phase of wound healing typically lasts for 1-2 days.
The granulation or proliferative phase involves fibroblast proliferation within the wound bed. These cells are responsible for the production of the collagen extracellular matrix. Cytokines present in the wound bed at this time also promote the process of angiogenesis and the appearance of granulation tissue, a characteristic of the healing wound. Once collagen is laid down as an extracellular matrix and cells have grown on this scaffold, the wound enters the remodeling phase of wound healing.
The remodeling phase involves the reassortment of collagen fibers laid down in the preceding proliferative phase. Remodeling is the longest period of the wound healing process; it may continue for up to a year. However, 2-3 weeks is a more common interval for this final phase of wound healing. During this time, the net amount of collagen does not increase, but the formation of a more orderly arrangement of fibers helps to greatly increase the wound's tensile strength. When healed properly, the final wound strength reaches 70-80% of prewound strength.
Pathophysiology
The ideal scar is narrow and fills but does not eclipse the original volume of the wound bed. In fact, the wound often decreases in size upon healing due to contractile forces involved in scar formation. Occasionally, scar formation may be exuberant, as in the cases of hypertrophic scarring or keloid formation. Although discussed in detail in Keloid and Hypertrophic Scar, a brief mention of these unwelcome sequelae of wound healing is warranted.
Hypertrophic scars do not extend beyond the original boundaries of the wound laterally, but scar tissue may rise above the level of the surrounding skin. This commonly results in a very noticeable, irregularly contoured scar. A more extreme example of exuberant growth of scar tissue is the keloid. Keloid scars extend beyond the original borders of the wound, resulting in a raised and expanded scar relative to the original defect. These are often very noticeable, and they occur with increased frequency in persons with dark complexions. In both hypertrophic scars and keloids, components of the extracellular matrix are increased. Thus, while the number of fibroblasts present is normal, the cells present are apparently overactive in their wound healing response.
Indications
The indications for scar revision are often a matter of patient preference. Scars on the head and neck are distressing to most patients. However, certain aspects of a scar, such as the color or texture, may bother one patient more than another. Patients should be counseled that a scar-free revision is not realistic and that an optimal result is achieved only through cooperation between patient and physician.
Contraindications
Cigarette smoking, nonsteroidal anti-inflammatory drugs, vitamin E, and isotretinoin should be stopped at the appropriate time prior to revision. Noninvasive or minimally invasive measures such as microdermabrasion and intralesional steroid injection can be performed as early as 3 weeks after revision of the scar, but many practitioners prefer to wait 6 weeks. When undertaking a revision, subtle problems should be treated conservatively first, before more aggressive interventions are used. Patients should be informed that the final maturation of the scar may take up to a year after revision. Above all, stress to the patient that scar revision merely replaces one scar with another in an attempt to improve the aesthetics of the area.
Complete restoration to the preinjury state is not possible under any circumstances, but the revised scar may be less detectable. A patient with realistic expectations is more likely to be satisfied with the final results of the revision procedures than a patient with unrealistic expectations.
Alster T, Zaulyanov L. Laser scar revision: a review. Dermatol Surg. Feb 2007;33(2):131-40. [Medline].
Alster TS, Lupton JR. Nonablative cutaneous remodeling using radiofrequency devices. Clin Dermatol. Sep-Oct 2007;25(5):487-91. [Medline].
Sobanko JF, Alster TS. Laser treatment for improvement and minimization of facial scars. Facial Plast Surg Clin North Am. Aug 2011;19(3):527-42. [Medline].
Pham AM, Greene RM, Woolery-Lloyd H, Kaufman J, Grunebaum LD. 1550-nm nonablative laser resurfacing for facial surgical scars. Arch Facial Plast Surg. May-Jun 2011;13(3):203-10. [Medline].
de Benito J, Fernández I, Nanda V. Treatment of depressed scars with a dissecting cannula and an autologous fat graft. Aesthetic Plast Surg. Sep-Oct 1999;23(5):367-70. [Medline].
Gold MH, Foster TD, Adair MA, Burlison K, Lewis T. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg. Jul 2001;27(7):641-4. [Medline].
Shockley WW. Scar revision techniques: z-plasty, w-plasty, and geometric broken line closure. Facial Plast Surg Clin North Am. Aug 2011;19(3):455-63. [Medline].
Alster TS, Lewis AB, Rosenbach A. Laser scar revision: comparison of CO2 laser vaporization with and without simultaneous pulsed dye laser treatment. Dermatol Surg. Dec 1998;24(12):1299-302. [Medline].
Borges AF. Timing of scar revision techniques. Clin Plast Surg. Jan 1990;17(1):71-6. [Medline].
Chen JS, Shack RB, Reinisch L, Spector N, Zinsser JW, Weisberg NK, et al. A comparison of scar revision with the free electron and carbon dioxide resurfacing lasers. Plast Reconstr Surg. Oct 2001;108(5):1268-75. [Medline].
de Noronha L, Chin EW, Menini CM, Knopfholz J, Rampazzo JC, Graf R. Histopathologic and morphometric evaluation of the skin abnormalities induced by erbium:YAG and carbon dioxide lasers in 10 patients. Plast Reconstr Surg. Oct 2001;108(5):1380-8. [Medline].
Engrav LH, Gottlieb JR, Millard SP, Walkinshaw MD, Heimbach DM, Marvin JA. A comparison of intramarginal and extramarginal excision of hypertrophic burn scars. Plast Reconstr Surg. Jan 1988;81(1):40-5. [Medline].
Frileck SP. Scar revision. Ann Plast Surg. Feb 1980;4(2):138-43. [Medline].
Goldberg D, Metzler C. Skin resurfacing utilizing a low-fluence Nd:YAG laser. J Cutan Laser Ther. Jan 1999;1(1):23-7. [Medline].
Goldberg DJ. Wheeland RG, ed. Cutaneous Surgery. ed. Philadelphia, Pa: WB Saunders; 1994:410-16.
Goldberg DJ. New collagen formation after dermal remodeling with an intense pulsed light source. J Cutan Laser Ther. Jun 2000;2(2):59-61. [Medline].
Goldberg DJ, Samady JA. Intense pulsed light and Nd:YAG laser non-ablative treatment of facial rhytids. Lasers Surg Med. 2001;28(2):141-4. [Medline].
Goldberg DJ, Silapunt S. Hair removal using a long-pulsed Nd:YAG Laser: comparison at fluences of 50, 80, and 100 J/cm. Dermatol Surg. May 2001;27(5):434-6. [Medline].
Goldberg DJ, Silapunt S. Histologic evaluation of a millisecond Nd:YAG laser for hair removal. Lasers Surg Med. 2001;28(2):159-61. [Medline].
Goldberg DJ, Silapunt S. Histologic evaluation of a Q-switched Nd:YAG laser in the nonablative treatment of wrinkles. Dermatol Surg. Aug 2001;27(8):744-6. [Medline].
Jeong JT, Kye YC. Resurfacing of pitted facial acne scars with a long-pulsed Er:YAG laser. Dermatol Surg. Feb 2001;27(2):107-10. [Medline].
Kaplan B, Potter T, Moy RL. Scar revision. Dermatol Surg. Jun 1997;23(6):435-42; quiz 443-4. [Medline].
Kiliç A, Kiliç A, Emsen IM, Ozdengil E. Lip scars camouflaged using microhair transplantation on male patients. Plast Reconstr Surg. Nov 2000;106(6):1340-1. [Medline].
Kwon SD, Kye YC. Treatment of scars with a pulsed Er:YAG laser. J Cutan Laser Ther. Mar 2000;2(1):27-31. [Medline].
Langdon RC. Regarding dermabrasion for acne scars. Dermatol Surg. Nov 1999;25(11):919-20. [Medline].
Lent WM, David LM. Laser resurfacing: a safe and predictable method of skin resurfacing. J Cutan Laser Ther. Apr 1999;1(2):87-94. [Medline].
Leung KS, Sher A, Clark JA, Cheng JC, Leung PC. Microcirculation in hypertrophic scars after burn injury. J Burn Care Rehabil. Sep-Oct 1989;10(5):436-44. [Medline].
Manuskiatti W, Fitzpatrick RE, Goldman MP. Energy density and numbers of treatment affect response of keloidal and hypertrophic sternotomy scars to the 585-nm flashlamp-pumped pulsed-dye laser. J Am Acad Dermatol. Oct 2001;45(4):557-65. [Medline].
Manuskiatti W, Fitzpatrick RE, Goldman MP. Treatment of facial skin using combinations of CO2, Q-switched alexandrite, flashlamp-pumped pulsed dye, and Er:YAG lasers in the same treatment session. Dermatol Surg. Feb 2000;26(2):114-20. [Medline].
McCraw JB, McCraw JA, McMellin A, Bettencourt N. Prevention of unfavorable scars using early pulse dye laser treatments: a preliminary report. Ann Plast Surg. Jan 1999;42(1):7-14. [Medline].
McGillis ST, Lucas AR. Scar revision. Dermatol Clin. Jan 1998;16(1):165-80. [Medline].
Sarwer DB, Whitaker LA, Pertschuk MJ, Wadden TA. Body image concerns of reconstructive surgery patients: an underrecognized problem. Ann Plast Surg. Apr 1998;40(4):403-7. [Medline].
Sawcer D, Lee HR, Lowe NJ. Lasers and adjunctive treatments for facial scars: a review. J Cutan Laser Ther. Apr 1999;1(2):77-85. [Medline].
Shim E, Tse Y, Velazquez E, Kamino H, Levine V, Ashinoff R. Short-pulse carbon dioxide laser resurfacing in the treatment of rhytides and scars. A clinical and histopathological study. Dermatol Surg. Jan 1998;24(1):113-7. [Medline].
Snow SN, Stiff MA, Lambert DR. Scalpel sculpturing techniques for graft revision and dermatologic surgery. J Dermatol Surg Oncol. Feb 1994;20(2):120-6. [Medline].
Staindl O, Chmelizek-Feurstein C. [Scars and scar revision]. HNO. Jun 1983;31(6):183-92. [Medline].
Walia S, Alster TS. Prolonged clinical and histologic effects from CO2 laser resurfacing of atrophic acne scars. Dermatol Surg. Dec 1999;25(12):926-30. [Medline].
Whitaker DC, Smith AC. A caution in the evaluation of scar revision. J Am Acad Dermatol. Feb 1993;28(2 Pt 1):269-70. [Medline].
Yang JY. Intrascar excision for persistent perioral hypertrophic scar. Plast Reconstr Surg. Dec 1996;98(7):1200-5; discussion 1206-7. [Medline].
Zide MF. Scar revision with hypereversion. J Oral Maxillofac Surg. Sep 1996;54(9):1061-7. [Medline].

